StockNews.AI
OWLT
StockNews.AI
203 days

Owlet Unveils ‘Owlet360' – Turning Infant Health Data Into Peace of Mind for Parents

1. Owlet launches Owlet360™, a new subscription service for infant health insights. 2. The service empowers parents with actionable data on their baby's health. 3. Owlet has tracked 1.7 million babies, building extensive pediatric health datasets. 4. Owlet360 notifies parents about key health metrics and trends daily. 5. Initial testing shows high engagement and satisfaction from users.

13m saved
Insight
Article

FAQ

Why Bullish?

The launch of a new subscription service can enhance revenue and growth potential.

How important is it?

This service can significantly transform engagement and revenue for OWLT.

Why Long Term?

Sustained subscription growth will likely take time but strengthen OWLT's market position.

Related Companies

OWLT
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces the launch of Owlet360™, a new subscription service available to Owlet customers. This innovative new service leverages the Company’s infant health and sleep data to provide caregivers a place to turn to for answers about their babies’ development and health, empowering them with actionable information – while ensuring Owlet’s core safety features, including live vitals monitoring and real-time alerts, remain free of charge. A New Era Of Parenting Confidence The demands on new parents are greater than ever. Caregivers often face sleepless nights, constant worry, and a lack of reliable resources to answer critical questions about their baby’s health and development. Frequently turning to friends or online resources, parents ask questions like, “Is this normal for my baby?” or “When should I take my baby to the doctor?” This uncertainty, coupled with high stress and fatigue, underscores the urgent need for a trusted, data-driven solution. Owlet360 helps solve this by providing actionable insights that aim to empower caregivers, support babies' well-being, and potentially reduce unnecessary healthcare visits. Data That Makes A Difference Since its inception, Owlet has monitored more than 1.7 million babies, tracked over 17 trillion heartbeats, and built one of the most extensive pediatric health datasets in the industry. This unmatched collection of data forms the backbone of Owlet360, enabling us to deliver insights no other platform can provide. Building on features existing Owlet users enjoy, Owlet360 allows caregivers to: Monitor Baby’s key health metrics by diving deeper into daily and weekly trends for pulse rate, oxygen level, movement, and comfort temperature. Compare Baby’s health and sleep data to the vast Owlet infant health data set, offering meaningful context and reassurance. Understand sleep and gain daily insights and guidance on Baby’s sleep patterns. Track Baby’s comfort temperature to let parents know if their baby is too warm or too cold and to adjust the sleeping environment. Watch, share, and save more video clips of Baby’s precious moments or important notifications, like when their baby is moving or crying is detected. View sleep environment insights like temperature and humidity trends in Baby’s room. Babies’ safety and parents’ peace of mind are the core of the Company’s mission. Access to key health and safety features, such as live vitals tracking and real-time alerts, is not changing. The Owlet Dream App will continue to provide pulse rate and oxygen level tracking, plus critical alerts, at no cost. Putting Actionable Insights Into Parents’ Hands "We believe the launch of Owlet360 marks a transformative moment not just for Owlet, but for the entire industry. With over a decade of experience pioneering at-home infant monitoring technology, we’ve built a deep understanding of what parents truly need – actionable insights, peace of mind, and a seamless way to track their baby’s health and development,” said Kurt Workman, Owlet Chief Executive Officer and Co-Founder. “Owlet360 is the next evolution of our connected ecosystem, leveraging our large pediatric health dataset to deliver personalized, proactive care. This is more than a subscription; it’s a new standard in parenting support." In its first months of testing with a limited set of Owlet users, Owlet360 became a trusted tool for caregivers, with the majority of subscribers using it daily. Parents tell us that having deeper insights into their babies’ health and sleep provides the confidence they need: “As a first-time mom, I am learning so much. I like the trends so I can see that she’s doing things just like other babies her age.” “Having statistics and averages of other babies who use Dream Sock is super helpful and comforting because if I get concerned about my baby's statistics, I can see that he is trending alongside other Owlet babies.” “I love that they show me exactly the type of rest that my baby is getting throughout the night and showing me where I need to help with improvement.” Owlet360 is available with a seven-day free trial for all new and existing Owlet Dream App users in the U.S. only, with plans to expand the service internationally later this year. Introductory pricing is $5.99 per month, with future plans for additional pricing options and expanded available features. To learn more, please visit www.owletcare.com/pages/owlet360. About Owlet, Inc. Owlet’s digital health infant monitoring platform is transforming the journey of parenting. The Company (NYSE: OWLT), a small-cap healthcare growth equity, offers FDA-authorized medical and consumer pediatric wearables and an integrated HD visual and audio camera that provide real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children. Since 2012, over 2 million parents worldwide have used Owlet’s platform contributing to one of the largest collections of consumer infant health and sleep data. The Company continues to develop software and digital data solutions to bridge the current healthcare gap between hospital and home and bring new insights to parents and caregivers globally. Owlet believes that every child deserves to live a long, happy, and healthy life. To learn more, visit www.owletcare.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company’s launch of its Owlet360 subscription service in the U.S. and the impacts, growth prospects, and expanded product and service offerings and availability in the U.S. and international markets. In some cases, you can identify forward-looking statements by terms such as “estimate,” “may,” “believes,” “plans,” “expects,” “anticipates,” “intends,” “goal,” “potential,” “upcoming,” “outlook,” “guidance,” the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company’s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by our forward-looking statements. Many important factors could affect the Company’s future results and cause those results to differ materially from those expressed in or implied by the Company’s forward-looking statements. Such factors include, but are not limited to, (i) the availability of, adoption and commercial success of Owlet360 within the U.S. and international markets, (ii) the regulatory pathway for the Company’s products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA and similar regulators outside of the U.S. as well as the Company’s ability to obtain and maintain regulatory approval or certification for our products and other regulatory requirements and legal proceedings; (iii) any developments in litigation in which the Company is involved, including the Butala and Cherian cases described in the Company’s reports filed with the U.S. Securities and Exchange Commission (the “SEC”); (iv) the ability of the Company to maintain listing of its Class A common stock on a national stock exchange; (v) the Company’s competition and the Company’s ability to profitably grow and manage growth; (vi) the Company’s ability to enhance future operating and financial results or obtain additional financing to continue as a going concern; (vii) risks associated with the Company’s current loan and debt agreements, including compliance with debt covenants, restrictions on the Company’s access to capital, the impact of the Company’s overall debt levels and the Company’s ability to generate sufficient future cash flows to meet the Company’s debt service obligations and operate its business; (viii) the ability of the Company to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (ix) the Company’s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements, including but not limited to requirements concerning privacy and data protection, breaches and loss, as well as other risks associated with the Company’s digital platforms and technologies; (x) the Company’s ability to maintain relationships with customers, manufacturers and suppliers and retain Owlet’s management and key employees; (xi) the Company’s ability to upgrade and maintain its information technology systems; (xii) changes in applicable laws or regulations; (xiii) the impact of and disruption to the Company’s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company’s control, such as health epidemics or pandemics, macro-economic uncertainties, social unrest, hostilities, natural disasters or other catastrophic events; (xiv) the possibility that the Company may be adversely affected by other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (xv) other risks and uncertainties set forth in the Company’s other releases, public statements and filings with the SEC, including those identified in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, subsequent Quarterly Reports on Form 10-Q, and any current or periodic reports filed with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and the Company can't predict such events or how they may affect the Company. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although the Company may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.

Related News